Fisher Asset Management LLC grew its holdings in Core Laboratories Inc. (NYSE:CLB – Free Report) by 21.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 753,555 shares of the oil and gas company’s stock after purchasing an additional 133,375 shares during the quarter. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $13,308,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the business. Russell Investments Group Ltd. grew its holdings in Core Laboratories by 48.3% during the 4th quarter. Russell Investments Group Ltd. now owns 112,290 shares of the oil and gas company’s stock worth $1,983,000 after acquiring an additional 36,560 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Core Laboratories by 33.4% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 138,951 shares of the oil and gas company’s stock valued at $2,454,000 after purchasing an additional 34,765 shares during the last quarter. GAMMA Investing LLC acquired a new position in Core Laboratories in the fourth quarter valued at about $48,000. Illinois Municipal Retirement Fund lifted its stake in Core Laboratories by 10.4% in the fourth quarter. Illinois Municipal Retirement Fund now owns 27,921 shares of the oil and gas company’s stock valued at $493,000 after buying an additional 2,641 shares during the period. Finally, Louisiana State Employees Retirement System bought a new position in Core Laboratories during the fourth quarter worth about $413,000. Institutional investors and hedge funds own 97.81% of the company’s stock.
Core Laboratories Stock Up 1.4 %
Shares of CLB stock opened at $15.92 on Monday. The company has a market capitalization of $746.65 million, a price-to-earnings ratio of 18.09, a P/E/G ratio of 0.90 and a beta of 2.40. Core Laboratories Inc. has a 12-month low of $13.82 and a 12-month high of $27.94. The firm has a fifty day moving average of $16.50 and a 200-day moving average of $17.30. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68.
Core Laboratories Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Monday, May 6th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.25%. The ex-dividend date of this dividend is Friday, May 3rd. Core Laboratories’s payout ratio is 4.55%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Stifel Nicolaus lifted their price objective on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America decreased their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating for the company in a report on Monday, April 15th. Finally, StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, January 20th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat, Core Laboratories has an average rating of “Hold” and a consensus price target of $18.75.
View Our Latest Analysis on CLB
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
- Five stocks we like better than Core Laboratories
- How to Use Stock Screeners to Find Stocks
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- Stock Market Upgrades: What Are They?
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.